The global Nystatin API market size is predicted to grow from US$ 37.27 million in 2025 to US$ 47.62 million in 2032; it is expected to grow at a CAGR of 3.6% from 2026 to 2032.

In 2025, global Nystatin API production reached approximately 128 tons, with an average global market price of around US$298 per kilogram. Nystatin API (Active Pharmaceutical Ingredient) is the raw material of a polyene - type antifungal drug. It is extracted from the culture broth of Streptomyces noursei and its main component is nystatin. It is a complex compound that belongs to the macrolide antibiotics family and has a conjugated polyene structure.

The global Nystatin API market is characterized by steady, clinically driven demand for topical and oral antifungal formulations, alongside structural differentiation between small-scale reagent supply and larger pharmaceutical API supply. Production predominantly relies on traditional fermentation, with technical differentiation focused on impurity profiles and potency assays; regulatory scrutiny of complex, multi-component APIs has increased the compliance and documentation burden. Trends favor formulation-readiness (micronization), improved process consistency and downstream formulation innovation that can reduce costs and broaden application. Demand-side opportunities arise from consolidation among generic producers, improved access in emerging markets, and potential expansion into veterinary and combination topical products. Key barriers include the intrinsic complexity of fermentation-based manufacture, difficulty controlling related substances and stability, the high costs of demonstrating batch-to-batch consistency for registration, and supply risks from geographic concentration of production. Firms that invest in scalable fermentation controls, advanced impurity analytics, robust stability packages, GMP alignment and supply-chain diversification will be best placed to mitigate risks and capture incremental demand.

Infinity Market Research newest research report, the Nystatin API Industry Forecast looks at past sales and reviews total world Nystatin API sales in 2025, providing a comprehensive analysis by region and market sector of projected Nystatin API sales for 2026 through 2032. With Nystatin API sales broken down by region, market sector and sub-sector, this report provides a detailed analysis in US$ millions of the world Nystatin API industry.

This Insight Report provides a comprehensive analysis of the global Nystatin API landscape and highlights key trends related to product segmentation, company formation, revenue, and market share, latest development, and M&A activity. This report also analyzes the strategies of leading global companies with a focus on Nystatin API portfolios and capabilities, market entry strategies, market positions, and geographic footprints, to better understand these firms unique position in an accelerating global Nystatin API market.

This Insight Report evaluates the key market trends, drivers, and affecting factors shaping the global outlook for Nystatin API and breaks down the forecast by Type, by Application, geography, and market size to highlight emerging pockets of opportunity. With a transparent methodology based on hundreds of bottom-up qualitative and quantitative market inputs, this study forecast offers a highly nuanced view of the current state and future trajectory in the global Nystatin API.

This report presents a comprehensive overview, market shares, and growth opportunities of Nystatin API market by product type, application, key manufacturers and key regions and countries.

Segmentation by Type:

    Nystatin Non-micronized
    Nystatin Micronized
    Nystatin Compacted
    Segmentation by Particle Size:
    Particle Size <45?m
    Particle Size <10?m

Segmentation by Application:

    External Preparations
    Oral Preparations

This report also splits the market by region:

    Americas
        United States
        Canada
        Mexico
        Brazil
    APAC
        China
        Japan
        Korea
        Southeast Asia
        India
        Australia
    Europe
        Germany
        France
        UK
        Italy
        Russia
    Middle East & Africa
        Egypt
        South Africa
        Israel
        Turkey
        GCC Countries

The below companies that are profiled have been selected based on inputs gathered from primary experts and analysing the companys coverage, product portfolio, its market penetration.

    Antibiotice
    Centrient Pharmaceuticals
    Duchefa Farma
    VUAB Pharma
    Hubei Hengshuo Chemical
    Concord Biotech

Key Questions Addressed in this Report

What is the 10-year outlook for the global Nystatin API market?
What factors are driving Nystatin API market growth, globally and by region?
Which technologies are poised for the fastest growth by market and region?
How do Nystatin API market opportunities vary by end market size?
How does Nystatin API break out by Type, by Application?